Voltar
Carta Revisado por pares
BIBTEX RIS

Single nucleotide polymorphisms in TP53 but not KRAS or MDM2 are predictive of clinical outcome in multiple myeloma treated with high-dose melphalan and autologous stem cell support

2015; Taylor & Francis; Volume: 57; Issue: 6 Linguagem: Inglês

10.3109/10428194.2015.1099648

ISSN

1042-8194

Autores

Niklas Gebauer, Harald Biersack, Ann-Cathrin Czerwinska, Janina Schemme, Tim Tristan Hardel, Veronica Bernard, Dirk Rades, Hendrik Lehnert, Kim Luley, Christoph Thorns,

Tópico(s)

Chronic Lymphocytic Leukemia Research

Resumo

Single-nucleotide polymorphisms (SNPs) of TP53 (codon 72, rs1042522), KRAS (LCS6 3’UTR, rs 61764370) and MDM2 promoter (SNP 309, rs2279744) have been associated with risk for various human cancers ...

Referência(s)